We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Synthetic Heart Valves Help Surgeons Improve Skills

By HospiMedica International staff writers
Posted on 15 Sep 2016
New polyvinyl materials make it possible for surgeons and medical residents to practice coronary artery bypass grafting (CABG) surgery using synthetic tissues, instead of cadavers.

Developed by researchers at the University of British Columbia Okanagan campus (UBC; Kelowna, Canada) and Kelowna General Hospital (KGH; Canada), the biomimetic platform uses a polyvinyl alcohol (PVA) hydrogel that mimics the geometric properties of vasculature, with features that approximate human tissue and with fairly consistent mechanical properties. More...
The researchers used the platform to create synthetic heart valves, arteries, and veins. They also simulated a case of autogenous saphenous vein CABG, which is placed from the aorta to the left anterior descending coronary artery.

They showed that the standard procedures of the CABG were successfully executed on the platform, suggesting that the proposed technology could also be applied to simulate other complicated surgeries such as end-to-end, side-to-end, and sequential anastomoses. The researchers are currently working towards creating a complete synthetic heart using the new PVA material, which could then be used to largely eliminate the need to use any animal or human cadaver tissues and organs when practicing heart surgery. The study was published on July 8, 2016, in Cardiovascular Engineering and Technology.

“One of the major issues with using arteries from human or animal cadavers is that they break down very quickly if they are not treated with preservatives. This synthetic material doesn't decompose and can't be contaminated, meaning doctors can practice their technique almost anywhere,” said lead author Hadi Mohammadi, PhD, of UBC. “An added benefit is that this material can be created safely and cheaply, which could solve any issues surgeons currently have in accessing practice materials.”

PVA is a colorless, water-soluble synthetic resin employed principally in the treatment of textiles and paper. It has excellent film forming, emulsifying, and adhesive properties, and is also resistant to oil, grease, and solvents. It has high tensile strength and flexibility, as well as high oxygen and aroma barrier properties. But these properties are dependent on humidity; water acts as a plasticizer, reducing its tensile strength, but increasing its elongation and tear strength.

Related Links:
University of British Columbia


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Ultrasound System
FUTUS LE
Infant Resuscitator
Easypuff
Pulmonary Ventilator
OXYMAG
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.